These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 1044248)

  • 1. Cefamandole: antimicrobial activity in vitro of a new cephalosporin.
    Meyers BR; Leng B; Hirschman SZ
    Antimicrob Agents Chemother; 1975 Dec; 8(6):737-41. PubMed ID: 1044248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibacterial activity of cefamandole in vitro.
    Meyers BR; Hirschman SZ
    J Infect Dis; 1978 May; 137 Suppl():S25-S31. PubMed ID: 349095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibacterial activity of cefamandole, a new cephalosporin antibiotic, compared with that of cephaloridine, cephalothin, and cephalexin.
    Eykyn S; Jenkins C; King A; Phillips I
    Antimicrob Agents Chemother; 1973 Jun; 3(6):657-61. PubMed ID: 4790616
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antimicrobial activity in vitro of cefaclor, a new oral cephalosporin.
    Meyers BR; Hirschman SZ
    J Clin Pharmacol; 1978; 18(2-3):85-90. PubMed ID: 624778
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative activities of the oxa-beta-lactam LY127935, cefotaxime, cefoperazone, cefamandole, and ticarcillin against multiply resistant gram-negative bacilli.
    Hall WH; Opfer BJ; Gerding DN
    Antimicrob Agents Chemother; 1980 Feb; 17(2):273-9. PubMed ID: 6247970
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cross-resistance between methicillin and cephalosporins for staphylococci: a general assumption not true for cefamandole.
    Frongillo RF; Bianchi P; Moretti A; Pasticci MB; Ripa S; Pauluzzi S
    Antimicrob Agents Chemother; 1984 May; 25(5):666-8. PubMed ID: 6563877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibacterial activity of cefuroxime, a new cephalosporin antibiotic, compared with that of cephaloridine, cephalothin, and cefamandole.
    Eykyn S; Jenkins C; King A; Phillips I
    Antimicrob Agents Chemother; 1976 Apr; 9(4):690-5. PubMed ID: 1267441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In-vitro activities of cefamandole and cephalothin against 1,881 clinical isolates. A multi-center study.
    Barry AL; Schoenknect FD; Shadomy S; Sherris JC; Thornsberry C; Washington JA; Kammer RB
    Am J Clin Pathol; 1979 Nov; 72(5):858-60. PubMed ID: 506998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative in vitro inhibitory and killing activity of cefpirome, ceftazidime, and cefotaxime against Pseudomonas aeruginosa, enterococci, Staphylococcus epidermidis, and methicillin-susceptible and -resistant and tolerant and nontolerant Staphylococcus aureus.
    Goldstein EJ; Citron DM
    Antimicrob Agents Chemother; 1985 Jul; 28(1):160-2. PubMed ID: 3929677
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cephalosporin susceptibility of methicillin-resistant, coagulase-negative staphylococci.
    Menzies RE; Cornere BM; MacCulloch D
    Antimicrob Agents Chemother; 1987 Jan; 31(1):42-5. PubMed ID: 3646002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro studies of cefamandole.
    Bodey GP; Weaver S
    Antimicrob Agents Chemother; 1976 Mar; 9(3):452-7. PubMed ID: 769679
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro antimicrobial activity of cefotaxime, a new cephalosporin.
    Masuyoshi S; Arai S; Miyamoto M; Mitsuhashi S
    Antimicrob Agents Chemother; 1980 Jul; 18(1):1-8. PubMed ID: 6251749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro evaluation of cefoxitin and cefamandole.
    Adams HG; Stilwell GA; Turck M
    Antimicrob Agents Chemother; 1976 Jun; 9(6):1019-24. PubMed ID: 820241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro activity of ceftaroline (PPI-0903M, T-91825) against bacteria with defined resistance mechanisms and phenotypes.
    Mushtaq S; Warner M; Ge Y; Kaniga K; Livermore DM
    J Antimicrob Chemother; 2007 Aug; 60(2):300-11. PubMed ID: 17548456
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the in vitro activities of HR756 with cephalothin, cefoxitin, and cefamandole.
    Sosna JP; Murray PR; Medoff G
    Antimicrob Agents Chemother; 1978 Dec; 14(6):876-9. PubMed ID: 742875
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cefuroxime, a beta-lactamase-resistant cephalosporin with a broad spectrum of gram-positive and -negative activity.
    Neu HC; Fu KP
    Antimicrob Agents Chemother; 1978 Apr; 13(4):657-64. PubMed ID: 248268
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro comparison of cefoxitin, cefamandole, cephalexin, and cephalothin.
    Eickhoff TC; Ehret JM
    Antimicrob Agents Chemother; 1976 Jun; 9(6):994-9. PubMed ID: 938029
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BL-S786 (ceforanide), a new parenteral cephalosporin: in vitro studies.
    Weaver SS; LeBlanc BM; Bodey GP
    Antimicrob Agents Chemother; 1979 Feb; 15(2):318-22. PubMed ID: 426520
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TOC-39, a novel parenteral broad-spectrum cephalosporin with excellent activity against methicillin-resistant Staphylococcus aureus.
    Hanaki H; Akagi H; Masaru Y; Otani T; Hyodo A; Hiramatsu K
    Antimicrob Agents Chemother; 1995 May; 39(5):1120-6. PubMed ID: 7625799
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the antibacterial activity of nine cephalosporins against Enterobacteriaceae and nonfermentative gram-negative bacilli.
    Verbist L
    Antimicrob Agents Chemother; 1976 Oct; 10(4):657-63. PubMed ID: 984801
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.